#SFHS2609113VNotice Regarding Prices of Pharmaceutical Specialties
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This notice sets the prices for certain pharmaceutical products offered by NEURAXPHARM FRANCE. These include specific dosages of TUZULBY, a slow-release chewable medication. Revised prices take effect four days after publication in France's official journal.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Sets new prices for TUZULBY medication
- Establishes pricing for different dosages
- New pricing effective four days post-publication
Obligations
What this law requires
Apply the following wholesale prices (PFHT) for TUZULBY products: 20 mg at €9.34, 30 mg at €11.90, and 40 mg at €15.31 per unit
Apply the following retail prices (PPTTC) for TUZULBY products: 20 mg at €10.92, 30 mg at €13.90, and 40 mg at €17.87 per unit
Implement the revised prices effective from the fourth day following publication in the Journal officiel de la République française
Ensure pricing compliance with the convention between the comité économique des produits de santé and NEURAXPHARM FRANCE